Skip to main content

Table 7 ADME properties of the newly designed compounds

From: Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors

Molecule

GI absorption

BBB permeant

Pgp substrate

Bioavailability score

Synthetic accessibility

Molecule 1

Low

No

No

0.55

4.67

Molecule 2

Low

No

No

0.55

4.88

Molecule 3

Low

No

No

0.55

4.67

Molecule 4

Low

No

No

0.55

4.66

Molecule 5

Low

No

No

0.55

4.67

Molecule 6

Low

No

No

0.55

4.67

Molecule 7

Low

No

No

0.55

4.67

Molecule 8

Low

No

No

0.55

4.87

Molecule 9

Low

No

No

0.17

5.16

Molecule 10

Low

No

No

0.55

4.84

Molecule 11

Low

No

No

0.55

4.86

Molecule 12

Low

No

No

0.55

4.83

Molecule 13

Low

No

No

0.17

4.68

Molecule 14

Low

No

No

0.17

4.69

Molecule 15

Low

No

No

0.55

4.87

Molecule 16

Low

No

No

0.55

4.87